ENANTA PHARMACEUTICALS, INC Investment Income, Interest
ENANTA PHARMACEUTICALS, INC (ENTA) reported Investment Income, Interest of $928.00 thousand for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2018-02-09
- ENANTA PHARMACEUTICALS, INC investment income, interest for the quarter ending 2017-12-31 was $928.00K, a 69.03% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC investment income, interest for the quarter ending 2017-09-30 was $783.00K, a 57.55% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC investment income, interest for the quarter ending 2017-06-30 was $628.00K, a 32.49% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC investment income, interest for the quarter ending 2017-03-31 was $572.00K, a 40.20% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC investment income, interest for fiscal 2017 was $2.53M, a 45.94% increase from fiscal 2016.
- ENANTA PHARMACEUTICALS, INC investment income, interest for fiscal 2016 was $1.74M, a 79.24% increase from fiscal 2015.
- ENANTA PHARMACEUTICALS, INC investment income, interest for fiscal 2015 was $968.00K, a 107.28% increase from fiscal 2014.
- ENANTA PHARMACEUTICALS, INC investment income, interest for fiscal 2014 was $467.00K, a 88.31% increase from fiscal 2013.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2017-12-31 | $928.00K 10-Q · filed 2018-02-09 | $1.71M derived: sum of 2 quarters · filed 2018-02-09 | $2.34M derived: sum of 3 quarters · filed 2018-02-09 | $2.91M derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-09-30 | $783.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $1.41M derived: sum of 2 quarters · filed 2017-12-11 | $1.98M derived: sum of 3 quarters · filed 2017-12-11 | $2.53M 10-K · filed 2017-12-11 |
| 2017-06-30 | $628.00K 10-Q · filed 2017-08-09 | $1.20M derived: sum of 2 quarters · filed 2017-08-09 | $1.75M 10-Q · filed 2017-08-09 | $2.25M derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-03-31 | $572.00K 10-Q · filed 2017-05-10 | $1.12M 10-Q · filed 2017-05-10 | $1.62M derived: sum of 3 quarters · filed 2018-02-09 | $2.09M derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-12-31 | $549.00K 10-Q · filed 2018-02-09 | $1.05M derived: sum of 2 quarters · filed 2018-02-09 | $1.52M derived: sum of 3 quarters · filed 2018-02-09 | $1.93M derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-09-30 | $497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $971.00K derived: sum of 2 quarters · filed 2017-12-11 | $1.38M derived: sum of 3 quarters · filed 2017-12-11 | $1.74M 10-K · filed 2017-12-11 |
| 2016-06-30 | $474.00K 10-Q · filed 2017-08-09 | $882.00K derived: sum of 2 quarters · filed 2017-08-09 | $1.24M 10-Q · filed 2017-08-09 | $1.55M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $408.00K 10-Q · filed 2017-05-10 | $764.00K 10-Q · filed 2017-05-10 | $1.07M derived: sum of 3 quarters · filed 2017-12-11 | $1.38M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $356.00K 10-Q · filed 2017-02-09 | $664.00K derived: sum of 2 quarters · filed 2017-12-11 | $968.00K derived: sum of 3 quarters · filed 2017-12-11 | $1.20M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $612.00K derived: sum of 2 quarters · filed 2017-12-11 | $841.00K derived: sum of 3 quarters · filed 2017-12-11 | $968.00K 10-K · filed 2017-12-11 |
| 2015-06-30 | $304.00K 10-Q · filed 2016-08-09 | $533.00K derived: sum of 2 quarters · filed 2016-08-09 | $660.00K 10-Q · filed 2016-08-09 | $798.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2015-03-31 | $229.00K 10-Q · filed 2016-05-10 | $356.00K 10-Q · filed 2016-05-10 | $494.00K derived: sum of 3 quarters · filed 2016-12-09 | $600.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-12-31 | $127.00K 10-Q · filed 2016-02-09 | $265.00K derived: sum of 2 quarters · filed 2016-12-09 | $371.00K derived: sum of 3 quarters · filed 2016-12-09 | $485.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-09-30 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | $244.00K derived: sum of 2 quarters · filed 2016-12-09 | $358.00K derived: sum of 3 quarters · filed 2016-12-09 | $467.00K 10-K · filed 2016-12-09 |
| 2014-06-30 | $106.00K 10-Q · filed 2015-08-10 | $220.00K derived: sum of 2 quarters · filed 2015-08-10 | $329.00K 10-Q · filed 2015-08-10 | $431.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $114.00K 10-Q · filed 2015-05-08 | $223.00K 10-Q · filed 2015-05-08 | $325.00K derived: sum of 3 quarters · filed 2015-12-11 | $389.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $109.00K 10-Q · filed 2015-02-06 | $211.00K derived: sum of 2 quarters · filed 2015-12-11 | $275.00K derived: sum of 3 quarters · filed 2015-12-11 | $322.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $166.00K derived: sum of 2 quarters · filed 2015-12-11 | $213.00K derived: sum of 3 quarters · filed 2015-12-11 | $248.00K 10-K · filed 2015-12-11 |
| 2013-06-30 | $64.00K 10-Q · filed 2014-08-12 | $111.00K derived: sum of 2 quarters · filed 2014-08-12 | $146.00K 10-Q · filed 2014-08-12 | $187.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2013-03-31 | $47.00K 10-Q · filed 2014-05-12 | $82.00K 10-Q · filed 2014-05-12 | $123.00K derived: sum of 3 quarters · filed 2014-12-11 | $171.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-12-31 | $35.00K 10-Q · filed 2014-02-13 | $76.00K derived: sum of 2 quarters · filed 2014-12-11 | $124.00K derived: sum of 3 quarters · filed 2014-12-11 | $139.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-09-30 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $89.00K derived: sum of 2 quarters · filed 2014-12-11 | $104.00K derived: sum of 3 quarters · filed 2014-12-11 | $118.00K 10-K · filed 2014-12-11 |
| 2012-06-30 | $48.00K 10-Q · filed 2013-08-12 | $63.00K derived: sum of 2 quarters · filed 2013-08-12 | $77.00K 10-Q · filed 2013-08-12 | |
| 2012-03-31 | $15.00K 10-Q · filed 2013-05-15 | $29.00K 10-Q · filed 2013-05-15 | ||
| 2011-09-30 | $83.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |